Related Experiment Video
Updated: Jan 28, 2026

Complementation of Splicing Activity by a Galectin-3 - U1 snRNP Complex on Beads
Published on: December 9, 2020
Galectin-3 is associated with arterial stiffness among hemodialysis patients
Qi Zhang1,2, Kanhua Yin3, Mingli Zhu2
1Division of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200011, PR China.
Insights
Galectin-3 is linked to arterial stiffness in hemodialysis patients. This finding suggests galectin-3 may be a biomarker for cardiovascular risk in this population.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Arterial stiffness is a significant cardiovascular risk factor in patients undergoing hemodialysis.
- Galectin-3, a protein involved in fibrosis and inflammation, has emerged as a potential biomarker for cardiovascular disease.
Purpose of the Study:
- To investigate the association between serum galectin-3 levels and arterial stiffness in patients receiving hemodialysis.
- To determine if galectin-3 is an independent predictor of arterial stiffness, even after accounting for traditional cardiovascular risk factors.
Main Methods:
- A cross-sectional study involving 311 hemodialysis patients.
- Arterial stiffness was assessed using pulse-wave velocity (PWV > 10 m/s).
- Serum galectin-3 concentrations were measured and correlated with clinical parameters and cardiovascular risk factors.
Main Results:
- Galectin-3 levels were associated with dialysis vintage, calcium, phosphorus, and low-density lipoprotein.
- After adjusting for multiple cardiovascular risk factors, galectin-3 remained independently associated with pulse-wave velocity (partial r = 0.130; p = 0.035).
- This association persisted even after further adjustment for mean arterial pressure and single-pool Kt/V (partial r = 0.139; p = 0.014).
Conclusions:
- Serum galectin-3 is independently associated with arterial stiffness in hemodialysis patients.
- Galectin-3 may serve as a valuable biomarker for assessing cardiovascular risk and arterial stiffness in this vulnerable population.
Abstract:
Aim: To evaluate the association between galectin-3 and arterial stiffness among hemodialysis patients. Methods: We enrolled 311 patients (median age: 61 years) with a median hemodialysis time of 90 months and a mean galectin-3 concentration of 29.78 ng/ml. Ninety-six (30.7%) had arterial stiffness diagnosed by the pulse-wave velocity over 10 m/s. Results: Galectin-3 was significantly associated with dialysis vintage, calcium, phosphorus and low-density lipoprotein. After adjustment for multiple cardiovascular risk factors, galectin-3 was independently associated with the pulse-wave velocity (partial r = 0.130; p = 0.035). This effect was still significant after additional adjustment for mean arterial pressure and single-pool Kt/V (partial r = 0.139; p = 0.014). Conclusion: Galectin-3 is independently associated with arterial stiffness among hemodialysis patients.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Arteries of Lower Limbs

